Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/40033
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPoh C.L.en
dc.contributor.authorCochrane A.en
dc.contributor.authorGalati J.C.en
dc.contributor.authorBullock A.en
dc.contributor.authorCelermajer D.S.en
dc.contributor.authorGentles T.en
dc.contributor.authordu Plessis K.en
dc.contributor.authorWinlaw D.S.en
dc.contributor.authorHornung T.en
dc.contributor.authorFinucane K.en
dc.contributor.authord'Udekem Y.en
dc.date.accessioned2021-05-14T13:41:30Zen
dc.date.available2021-05-14T13:41:30Zen
dc.date.copyright2016en
dc.date.created20160312en
dc.date.issued2016-03-12en
dc.identifier.citationEuropean Journal of Cardio-thoracic Surgery. 49 (2) (pp 530-535), 2016. Date of Publication: 01 Feb 2016.en
dc.identifier.issn1010-7940en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/40033en
dc.description.abstractOBJECTIVE: To investigate the benefits of a strategy of early Fontan conversion. METHOD(S): Using the Australia and New Zealand Fontan Registry, retrospective analysis of their long-term follow-up data was performed. RESULT(S): Between 1990 and 2014, a total of 39 patients underwent surgical conversion in 6 centres at a median age of 23.8 years (IQR: 19.3-28.2), 18.7 +/- 5.0 years post-Fontan. One centre tended to perform conversion earlier: Interval since first documented arrhythmia 2.9 +/- 4.0 vs 4.0 +/- 4.2 years, average NYHA Class 2 +/- 0.4 vs 3 +/- 0.9 (P = 0.008), mean number of preop anti-arrhythmics 1 +/- 0.4 vs 2 +/- 0.6 (P = 0.05). Two patients underwent conversion to an extracardiac conduit only, while 36 had concomitant right atrial cryoablation, of which 16 also had pacemaker implantation. Nine patients suffered major cardiac-related complications (7 low output syndrome, 3 ECMO, 3 acute renal failure, one stroke) (2/17 from the early conversion centre and 7/22 of the others; P = 0.14). Four patients died in hospital (10.3%) and 4 late after a median of 0.9 years [95% confidence interval (CI): 0.5-1] after conversion. An additional 2 patients needed transplantation at 1 and 8.8 years after conversion, respectively. The 10-year freedom from heart transplantation was 86% (95% CI: 51-97%). Outcomes from the centre with an early conversion strategy were significantly better: 8-year freedom from death or heart transplantation was 86% (95% CI: 53-96) vs 51% (95% CI: 22-74; log-rank P = 0.007). Eight additional patients required pacemaker implantation and 5 had arrhythmia recurrence. CONCLUSION(S): Fontan conversion is associated with lasting survival outcomes up to 10 years after conversion. A strategy of surgical conversion at earlier stage of failure may be associated with better survival free from transplantation.Copyright © The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.en
dc.languageEnglishen
dc.languageenen
dc.publisherEuropean Association for Cardio-Thoracic Surgery (E-mail: info@eacts.co.uk)en
dc.relation.ispartofEuropean Journal of Cardio-thoracic Surgeryen
dc.titleTen-year outcomes of Fontan conversion in Australia and New Zealand demonstrate the superiority of a strategy of early conversion. [European Journal of Cardio-thoracic Surgery]en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1093/ejcts/ezv112en
dc.publisher.placeUnited Kingdomen
dc.identifier.source608909622en
dc.identifier.institution(Poh, Galati, du Plessis, d'Udekem) Murdoch Children's Research Institute, Melbourne, VIC, Australia (Poh, d'Udekem) Department of Paediatrics, Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia (Cochrane) Department of Cardiothoracic Surgery, Monash Medical Centre, Monash University Faculty of Medicine, Melbourne, VIC, Australia (Galati) Department of Mathematics and Statistics, La Trobe University, Melbourne, VIC, Australia (Bullock) Children's Cardiac Centre, Princess Margaret Hospital for Children, Perth, WA, Australia (Celermajer) Department of Medicine, The University of Sydney, Sydney, NSW, Australia (Celermajer) Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia (Gentles, Hornung, Finucane) Green Lane Paediatric and Congenital Cardiac Service, Starship Children's Hospital Auckland, Auckland, New Zealand (Winlaw) Heart Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia (d'Udekem) The Royal Children's Hospital, Melbourne, VIC, Australiaen
dc.description.addressY. d'Udekem, Department of Cardiac Surgery, Royal Children's Hospital, Flemington Road, Parkville, Melbourne, VIC 3052, Australia. E-mail: yves.dudekem@rch.org.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2016 Elsevier B.V., All rights reserved.en
dc.subect.keywordsAtriopulmonary Fontan Fontan conversion Fontan procedure Long-term outcomesen
dc.identifier.authoremaild'Udekem Y.; yves.dudekem@rch.org.auen
dc.description.grantNo: 1076849 Organization: (NHMRC) *National Health and Medical Research Council*en
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
crisitem.author.deptCardiology (MonashHeart & Victorian Heart Institute)-
crisitem.author.deptCardiothoracic Surgery-
Appears in Collections:Articles
Show simple item record

Page view(s)

28
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.